High-pro­file R&D spe­cial­ist David Leb­wohl jumps to new job as CMO of a pi­o­neer­ing CRISPR play­er; Trou­bled AM­AG Phar­ma­ceu­ti­cals taps Scott My­ers as CEO

→ No­var­tis vet David Leb­wohl has found a new biotech to ply his trade.

A lit­tle more than a year ago, Leb­wohl joined the great …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.